Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.21 (
beta-glucosidase
)
3,280
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the involvement of bacterial enzyme activities in the biotransformation of
xenobiotic
compounds, we have developed a simulation of the rat hindgut microflora in vitro. This mixed bacterial population exhibits many similarities to the native rat flora, and the diversity of bacterial species and the activity of a number of hydrolytic and reductive enzymes (e.g. azoreductase,
beta-glucosidase
, beta-glucuronidase, nitrate reductase and nitroreductase) are reproduced in the culture at levels similar to those found in the large intestine. The flora have been found to respond to an anutrient (cyclamate) or to host products (bile acids) with changes in enzyme activity, and to metabolize the azo dye Brown HT to metabolites qualitatively similar to those found in the faeces after oral administration to the rat. The experiments demonstrate that the bacterial population of the large intestine of the rat may be successfully cultured in vitro and provides and alternative to animal studies for the investigation of foreign compound metabolism by the flora.
...
PMID:The use of continuous flow systems for studying the metabolic activity of the hindgut microflora in vitro. 243 Aug 72
We have isolated from guinea-pig liver a broad-specificity
beta-glucosidase
of unknown function that utilizes as its substrate non-physiological aryl glycosides (e.g. 4-methylumbelliferyl beta-D-glucopyranoside, p-nitrophenyl beta-D-glucopyranoside). The present paper documents that this enzyme can be inhibited by various naturally occurring glycosides, including L-picein, dhurrin and glucocheirolin. In addition, L-picein, which acts as a competitive inhibitor of the broad-specificity
beta-glucosidase
(Ki 0.65 mM), is also a substrate for this enzyme (Km 0.63 mM; Vmax. 277,000 units/mg). Heat-denaturation, kinetic competition studies, chromatographic properties and pH optima all argue strongly that the broad-specificity
beta-glucosidase
is responsible for the hydrolysis of both the non-physiological aryl glycosides and L-picein. This paper demonstrates that
beta-glucosidase
can catalyse the hydrolysis of a natural glycoside, and may provide a key to understanding the function of this enigmatic enzyme. A possible role in the metabolism of
xenobiotic
compounds is discussed.
...
PMID:Hydrolysis of a naturally occurring beta-glucoside by a broad-specificity beta-glucosidase from liver. 309 56
Human cytosolic beta-glucosidase (hCBG) is a
xenobiotic
-metabolizing enzyme that hydrolyses certain flavonoid glucosides, with specificity depending on the aglycone moiety, the type of sugar and the linkage between them. Based upon the X-ray structure of Zea mays
beta-glucosidase
, we generated a three-dimensional model of hCBG by homology modelling. The enzyme exhibited the (beta/alpha)(8)-barrel fold characteristic of family 1 beta-glucosidases, with structural differences being confined mainly to loop regions. Based on the substrate specificity of the human enzymes, sequence alignment of family 1 enzymes and analysis of the hCBG structural model, we selected and mutated putative substrate (aglycone) binding site residues. Four single mutants (Val(168)-->Tyr, Phe(225)-->Ser, Tyr(308)-->Ala and Tyr(308)-->Phe) were expressed in Pichia pastoris, purified and characterized. All mutant proteins showed a decrease in activity towards a broad range of substrates. The Val(168)-->Tyr mutation did not affect K (m) on p -nitrophenyl ( p NP)-glycosides, but increased K (m) 5-fold on flavonoid glucosides, providing the first biochemical evidence supporting a role for this residue in aglycone-binding of the substrate, a finding consistent with our three-dimensional model. The Phe(225)-->Ser and Tyr(308)-->Ala mutations, and, to a lesser degree, the Tyr(308)-->Phe mutation, resulted in a drastic decrease in specific activities towards all substrates tested, indicating an important role of those residues in catalysis. Taken together with the three-dimensional model, these mutation studies identified the amino-acid residues in the aglycone-binding subsite of hCBG that are essential for flavonoid glucoside binding and catalysis.
...
PMID:Substrate (aglycone) specificity of human cytosolic beta-glucosidase. 1266 41
Metabolic fate of xenobiotics in plant tissues has an important role in the ultimate fate of these compounds in natural and engineered systems. Chlorophenols are an important class of xenobiotics used in a variety of biocides and have been shown to be resistant to microbial degradation. Three chlorophenyl glycosides were extracted from tissues of Lemna minor exposed to 2,4-dichlorophenol (DCP). The products were identified as 2,4-dichlorophenyl-beta-D-glucopyranoside (DCPG), 2,4-dichlorophenyl-beta-D-(6-O-malonyl)-glucopyranoside (DCPMG) and 2,4-dichlorophenyl-beta-D-glucopyranosyl-(6 --> 1)-beta-D-apiofuranoside (DCPAG). Identification was based on reverse phase retention (C18), electrospray mass spectra collected in negative and positive mode (ESI-NEG and ESI-POS, respectively), and nuclear magnetic resonance (NMR) spectra comparisons to reference materials synthesized in the laboratory. Liquid chromatography-mass spectrometry (LC-MS) analysis of plants exposed to 2,4,5-trichlorophenol (TCP) formed analogous compounds: 2,4,5-trichlorophenyl-beta-D-glucopyranoside (TCPG), 2,4,5-trichlorophenyl-beta-D-(6-O-malonyl)-glucopyranoside (TCPMG) and 2,4,5-trichlorophenyl-beta-D-glucopyranosyl-(6 --> 1)-beta-D-apiofuranoside (TCPAG). Enzyme catalyzed hydrolysis with
beta-glucosidase
was ineffective in releasing the beta-glucosides with chemical modifications at C6. Presence of these glucoconjugates confirmed that L. minor was capable of
xenobiotic
uptake and transformation. Identification of these products suggested that chlorophenols were incorporated into vacuoles and cell walls of L. minor.
...
PMID:Glycosidation of chlorophenols by Lemna minor. 1528 53
The aquatic crustacean Daphnia magna is an important species for ecotoxicological study, and is often used as a test organism for environmental risk assessment. However, the mechanism of
xenobiotic
metabolism by this species has not been studied in detail. In the present study, pyrene was used as model substance to investigate the mechanism of
xenobiotic
metabolism in D. magna. The results of 24-h exposure experiments showed that D. magna could metabolize pyrene and biotransform it into water-soluble metabolites. On the other hand, the metabolism of pyrene was significantly inhibited by SKF-525A as the cytochrome P450 (CYP) inhibitor. These observations indicated that oxidation by CYP participated in the biotransformation of pyrene by D. magna. We also identified the pyrene metabolites formed by D. magna by HPLC with an electrospray ionization triple quadrupole mass spectrometry detector (LC/ESIMS/MS) and de-conjugation by sulfatase, beta-glucuronidase, and
beta-glucosidase
. One of the metabolites was ionized in ESI negative mode and formed a dominant mass of m/z 297 (MS) with the product ion of m/z 217 (MS2). Furthermore, this metabolite formed 1-hydroxypyrene on treatment with sulfatase. This metabolite was considered to be a sulfate conjugate of oxidized pyrene (1-hydroxypyrenesulfate). Furthermore, we quantified the deconjugated 1-hydroxypyrene formed by the above enzyme treatment. It showed that 52% of the total metabolized pyrene was biotransformed into 1-hydroxypyrene-sulfate, and more than 73% was biotransformed into oxidized pyrene conjugate. These results indicated that CYP and several conjugation enzymes participate in its biotransformation, and sulfation is important in D. magna for metabolism and elimination of xenobiotics.
...
PMID:Metabolism of pyrene by aquatic crustacean, Daphnia magna. 1697 24